Inform your doctor of all medications, supplements, and health conditions that apply to you before taking Linzess to prevent possible interactions. Linzess may interact with antidiarrheal and ...
Shares of Ironwood Pharmaceuticals (IRWD) added ~31% on Friday to hit a new 52-week high after the company set its 2026 ...
Stocktwits on MSN
Why did Ironwood Pharmaceuticals stock skyrocket today?
The outlook assumes net sales for Linzess will be between $1.125 billion and $1.175 billion in FY2026. ・U.S. FDA had approved ...
Trulance (plecanatide) and Linzess (linaclotide) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat two types of constipation in adults: ...
Linzess is a prescription medication for adults that treats irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). The typical dosage of Linzess for IBS-C is 290 ...
Beyond LINZESS, Ironwood is advancing its pipeline with apraglutide, a next-generation long-acting synthetic GLP-2 analog being developed for short bowel syndrome with intestinal failure (SBS-IF). The ...
Linzess may interact with anticholinergic drugs, such as oxybutynin (Ditropan XL), and antidiarrheal drugs, such as loperamide (Imodium). Taking these drugs with Linzess can make Linzess less ...
Credit: Shutterstock. Linzess is a guanylate cyclase-C agonist. The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the treatment of functional constipation (FC) in ...
Many Medicare Part D plans cover Linzess, but out-of-pocket costs can vary because private insurance companies manage these plans. Linzess is an expensive medication with no generic alternatives ...
Backs FY25 adjusted EBITDA view greater than $135M. “Throughout 2025, we made significant progress in maximizing LINZESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback